News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,420 Results
Type
Article (2677)
Company Profile (45)
Press Release (37697)
Multimedia
Podcasts (14)
Webinars (2)
Section
Business (14282)
Career Advice (78)
Deals (2116)
Drug Delivery (10)
Drug Development (4326)
Employer Resources (10)
FDA (480)
Job Trends (798)
News (20622)
Policy (1142)
Tag
Academia (145)
Adcomms (1)
Allergies (7)
Alliances (3499)
ALS (5)
Alzheimer's disease (54)
Antibody-drug conjugate (ADC) (24)
Approvals (471)
Artificial intelligence (28)
Autoimmune disease (9)
Automation (2)
Bankruptcy (12)
Best Places to Work (495)
BIOSECURE Act (2)
Biosimilars (17)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (6)
Breast cancer (43)
Cancer (314)
Cardiovascular disease (10)
Career advice (66)
Career pathing (1)
CAR-T (28)
CDC (21)
Cell therapy (79)
Cervical cancer (2)
Clinical research (3570)
Collaboration (184)
Company closure (2)
Compensation (99)
COVID-19 (204)
CRISPR (11)
C-suite (96)
Cystic fibrosis (6)
Data (400)
Denatured (6)
Depression (11)
Diabetes (22)
Diagnostics (480)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (29)
Drug pricing (10)
Duchenne muscular dystrophy (39)
Earnings (4543)
Editorial (13)
Employer branding (1)
Employer resources (8)
Events (6433)
Executive appointments (129)
FDA (622)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (154)
Gene editing (30)
Generative AI (1)
Gene therapy (52)
GLP-1 (64)
Government (212)
Guidances (23)
Healthcare (722)
Huntington's disease (5)
IgA nephropathy (11)
Immunology and inflammation (33)
Immuno-oncology (11)
Indications (4)
Infectious disease (222)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (10)
Intellectual property (24)
Interviews (7)
IPO (1016)
IRA (7)
Job creations (295)
Job search strategy (62)
Kidney cancer (6)
Labor market (12)
Layoffs (53)
Leadership (3)
Legal (219)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (2)
Management (4)
Manufacturing (49)
MASH (13)
Medical device (312)
Medtech (312)
Mergers & acquisitions (1216)
Metabolic disorders (73)
Multiple sclerosis (20)
Neurodegenerative disease (24)
Neuropsychiatric disorders (8)
Neuroscience (155)
NextGen: Class of 2025 (355)
Non-profit (155)
Now hiring (10)
Obesity (30)
Opinion (19)
Ovarian cancer (17)
Pain (23)
Pancreatic cancer (20)
Parkinson's disease (10)
Partnered (4)
Patents (51)
Patient recruitment (21)
Peanut (1)
People (5874)
Pharmaceutical (5)
Phase I (1516)
Phase II (1768)
Phase III (951)
Pipeline (340)
Policy (48)
Postmarket research (33)
Preclinical (646)
Press Release (2)
Prostate cancer (7)
Psychedelics (2)
Radiopharmaceuticals (13)
Rare diseases (52)
Real estate (425)
Recruiting (5)
Regulatory (959)
Reports (8)
Research institute (148)
Resumes & cover letters (9)
Rett syndrome (1)
RNA editing (5)
RSV (2)
Schizophrenia (16)
Series A (41)
Series B (18)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (498)
Stomach cancer (2)
Supply chain (5)
Tariffs (2)
The Weekly (7)
Vaccines (100)
Venture capital (14)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Today (5)
Last 7 days (39)
Last 30 days (186)
Last 365 days (2525)
2025 (2518)
2024 (2655)
2023 (2903)
2022 (3784)
2021 (4084)
2020 (3517)
2019 (2127)
2018 (1607)
2017 (1813)
2016 (1637)
2015 (1860)
2014 (1386)
2013 (1197)
2012 (1401)
2011 (1341)
2010 (1193)
Location
Africa (44)
Alabama (3)
Arizona (16)
Asia (1962)
Australia (309)
California (1524)
Canada (235)
China (78)
Colorado (47)
Connecticut (15)
Delaware (5)
Europe (4033)
Florida (61)
Georgia (15)
Hawaii (2)
Idaho (3)
Illinois (19)
India (2)
Indiana (54)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (46)
Massachusetts (545)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (2)
New Jersey (128)
New York (76)
North Carolina (129)
Northern California (732)
Ohio (41)
Oklahoma (2)
Oregon (5)
Pennsylvania (101)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (624)
Tennessee (4)
Texas (147)
United States (3054)
Utah (4)
Virginia (10)
Washington D.C. (3)
Washington State (89)
West Virginia (1)
Wisconsin (10)
40,420 Results for "antiva biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Antiva Biosciences Announces Formation of Scientific and Development Advisory Board
Antiva Biosciences announced the formation of a scientific and development advisory board featuring distinguished thought leaders from both academia and industry with clinical expertise spanning the fields of women’s health and virology.
June 13, 2024
·
7 min read
Business
Antiva Biosciences Strengthens Leadership with Key New Appointments
Antiva Biosciences today announced several key new appointments designed to strengthen the company’s leadership as it continues to advance its lead development candidate, ABI-2280.
October 19, 2023
·
6 min read
Biotech Bay
Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital and Names Kristine Ball President and CEO
Antiva Biosciences today announced the closing of a $53 million Series E equity financing.
April 27, 2023
·
6 min read
Press Releases
Droplet Biosciences-Study Reveals Post-Surgical Lymph Fluid as a Powerful Source of ctDNA for Early Recurrence Detection in Head & Neck Cancer
November 14, 2025
·
4 min read
Biotech Bay
Antiva Biosciences Closes $31 Million Series D Equity Financing
Antiva Biosciences today announced the closing of a $31 million Series D equity financing.
November 2, 2021
·
5 min read
Press Releases
Xcell Biosciences and Culture Biosciences Partner to Advance Cell Therapy Quality Through AI and Machine Learning
December 10, 2025
·
4 min read
Press Releases
Neurocrine Biosciences Provides Update on Phase 3 Study of Valbenazine in Dyskinetic Cerebral Palsy
December 23, 2025
·
6 min read
Press Releases
Jade Biosciences Announces $45 Million Private Placement
December 15, 2025
·
5 min read
Press Releases
Alligator Bioscience Publishes Financial Calendar for 2026
December 3, 2025
·
1 min read
Press Releases
VYNE Therapeutics and Yarrow Bioscience Announce Merger Agreement
December 18, 2025
·
14 min read
1 of 4,042
Next
